Continuous infusion administration of Taxol in women with ovarian carcinoma who have failed 3 chemotherapy regimens and are platinum resistant. Study will define objective response rate of ovarian cancer to Taxol and the toxicities of Taxol.
Showing the most recent 10 out of 674 publications